Stopped manufacturing, supply of additional Covishield doses, disclosed all side effects: Serum Institute
AstraZeneca has voluntarily withdrawn the "marketing authorisation" of its Covid vaccine, sold as Covishield in India and Vaxzevria in Europe.
AstraZeneca has voluntarily withdrawn the "marketing authorisation" of its Covid vaccine, sold as Covishield in India and Vaxzevria in Europe.
The statement further said that Covovax is the fourth vaccine to receive EUA from the DCGI for use among adolescents 12 and older.
It is to be noted that the government has not given indemnity to any vaccine companies from severe side effects as of now.
With constant encouragement of the government, Serum Institute is ramping up Covishield production of 6.5 crore doses per month to 11.0 crore doses per month
